A new vaccine for RSV for elderly may potentially increase the risk for Guillain-Barre syndrome (GBS), a rare neurologic disorder, the US Food and Drug Administration (FDA) has said.

Source: https://www.canindia.com/pfizers-rsv-shot-for-elderly-linked-to-guillain-barre-risk-us-fda/

GSK rose after the US Food and Drug Administration accepted an initial filing for its cancer drug, Jemperli, when combined with chemotherapy to treat adult patients with certain types of endometrial cancer.

Source: https://www.dailymail.co.uk/money/markets/article-12165947/MARKET-REPORT-Global-defence-spending-splurge-boosts-Chemring.html?ns_mchannel=rss&ns_campaign=1490&ito=1490

Importantly, Nuleaf Naturals is cGMP certified which means they follow the current Good Manufacturing Practices laid down by the US Food and Drug Administration.

Source: https://www.healthcanal.com/health/nuleaf-naturals-review

The study looked at 60 drugs approved by the US Food and Drug Administration (FDA) between 2009 and 2018.

Source: https://medcitynews.com/2023/11/the-disconnect-between-rd-costs-and-high-drug-prices/

The US Food and Drug Administration (FDA) on Wednesday, May 3, 2023, approved the world’s first respiratory syncytial virus vaccine.

Source: https://pragativadi.com/worlds-first-respiratory-syncytial-virus-vaccine-gets-fda-nod/?utm_source=rss&utm_medium=rss&utm_campaign=worlds-first-respiratory-syncytial-virus-vaccine-gets-fda-nod